We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Zealand Adds Pfizer’s Champix to Smoking Cessation Arsenal
New Zealand Adds Pfizer’s Champix to Smoking Cessation Arsenal
November 17, 2010
New Zealand’s drug-purchasing agency Pharmac has agreed to fully reimburse patients who use Pfizer’s smoking cessation drug Champix despite earlier concerns about the drug’s safety.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor